Navigation Links
CDC's National Center for Environmental Health Works with Thomson Reuters to Help Identify and Track Illnesses Related to Harmful Algal Blooms
Date:7/2/2009

ANN ARBOR, Mich., July 2 /PRNewswire/ -- Thomson Reuters is working with the Centers for Disease Control's (CDC) National Center for Environmental Health to support development of the CDC's Harmful Algal Bloom-related Illness Surveillance System (HABISS).

This unique system collects data on human and animal health and on the environmental effects of harmful algal blooms (HABs).

As part of the project, the National Center for Environmental Health developed new case definitions for HAB toxin-related diseases which Thomson Reuters has incorporated into its Micromedex POISINDEX(R) System. POISINDEX is a toxicology database used by all U.S. Poison Control Centers serving the 50 states, Puerto Rico, U.S. Virgin Islands, and three Pacific jurisdictions. With the new case definitions, clinicians can determine quickly whether a case is consistent with HAB exposure and, if so, alert the CDC using contact information included in the POISINDEX entries.

Data collection in HABISS is underway in 13 states. Stored data will be used to help predict local HABs so state health and environmental officials can respond to reports of human and animal illnesses and anticipate public health problems.

"Harmful algal blooms are a real problem in many areas of the country, and can release toxins dangerous to humans and animals," said Dr. Lorraine Backer, senior scientist at the National Center for Environmental Health and leader in the HABISS project. "Working with Thomson Reuters' toxicology team to add the new HAB case definitions to POISINDEX puts the information needed to help identify and report suspected cases of HAB exposure at the fingertips of Poison Control Centers and hospital staff. This is a real plus for the HABISS project and CDC's efforts to improve public health."

The POISINDEX System builds on Thomson Reuters' database of more than 350,000 consumer, industrial, and pharmaceutical products, ensuring ready access to current, accurate, and comprehensive information needed to address poisoning or toxicity issues.

"Thomson Reuters is proud to work closely with the CDC on emerging public health issues such as harmful algal blooms," said Thomas Hegelund, executive vice president for the Healthcare & Science business of Thomson Reuters. "We are dedicated to providing the most up-to-date, accurate, and comprehensive reference information to the healthcare community."

About Thomson Reuters

Thomson Reuters is the world's leading source of intelligent information for businesses and professionals. We combine industry expertise with innovative technology to deliver critical information to leading decision makers in the financial, legal, tax and accounting, scientific, healthcare and media markets, powered by the world's most trusted news organization. With headquarters in New York and major operations in London and Eagan, Minnesota, Thomson Reuters employs more than 50,000 people in 93 countries. For more information, go to www.thomsonreuters.com.


'/>"/>
SOURCE Thomson Reuters
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. International Collaboration led by Dr. Pablo V. Gejman,Researcher At NorthShore University HealthSystem's Research Institute, Finds Genetic Association of Schizophrenia to Chromosome 6p Variant
2. TeamHealth Recognized by National Quality Agency
3. Tempe-Based Marketing Agency Receives Prestigious National Healthcare Marketing Award, Several Regional Awards
4. Christian Childrens Fund Name Change to ChildFund International Official
5. AIUM announces management agreement with the International Society of Therapeutic Ultrasound
6. Intelligent Hospital Systems Receives International Award for Innovative Technology Benefiting Society
7. CVS/pharmacy and MinuteClinic Receive Award of Excellence from National Influenza Vaccine Summit
8. National Healthcare Providers Select onFocus epm(TM) To Help Ensure Success on Financial and Strategic Objectives
9. IU School of Optometry named national vision research center
10. The National Council on Aging and CVS/pharmacy Educate Pennsylvania Seniors on Medication Management and How to Save Money on Prescription Drugs
11. Jackson International Launches New Website in Collaboration with Medicaview International
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... ... December 02, 2016 , ... On Dec. 2, 2016, CURE® magazine will ... Diego honoring the 2016 MPN Heroes—eight individuals who have made a difference in the ... beyond the standard of care, demonstrating leadership within the MPN community and/or a commitment ...
(Date:12/2/2016)... ... December 02, 2016 , ... More than 100 business, civic, ... to attend the UNCF Dothan-Wiregrass Mayor’s Luncheon Dec. 9, 2016. This inaugural event, ... and operating support to UNCF-member institutions, including Miles College, Oakwood University, Tuskegee University, ...
(Date:12/2/2016)... ... December 02, 2016 , ... ... launch of its 60-day free trial program for all of the company’s desktop ... offer a truly hassle free experience. , FlexiSpot’s unique desktop risers use an ...
(Date:12/2/2016)... ... 2016 , ... The annual time frame to change Medicare health and prescription ... December 7th. Currently-enrolled Medicare beneficiaries who are looking to switch from their current plan ... to make changes during this period order for their new policy to go into ...
(Date:12/2/2016)... ... December 02, 2016 , ... With the number of pain ... an injury, patients must find the one that works for them. When an inventor ... a machine that worked and decided to share it with others. , He developed ...
Breaking Medicine News(10 mins):
(Date:12/2/2016)... British Columbia , December 2, 2016 bioLytical ... bekannt gegeben, ab diesem Monat seinen  INSTI HIV-Selbsttests  in einer Version mit ... ... New: INSTI Self Test! ... , ,      (Photo: ...
(Date:12/2/2016)... The iShares Nasdaq Biotechnology Exchange-Traded Fund ... victory early in November. Less political risk has boosted ... predicting an uptick in M&A activities. Today, Stock-Callers.com takes ... they have fared at the last close: Celldex Therapeutics ... (NASDAQ: FOLD ), Navidea Biopharmaceuticals Inc. (NYSE ...
(Date:11/30/2016)... Nov 30, 2016 Research and ... Overview for Neuromodulation, Neurovascular, Neurosurgical and Monitoring Devices 2017 - ... ... The full report suite on the U.S. market ... drainage systems, intracranial pressure monitoring devices, detachable coils, liquid embolics, ...
Breaking Medicine Technology: